← All trials
NCT01301924
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2008
- Primary completion
- Apr 1, 2016
- Completion date
- Dec 1, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 264
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Oswaldo Cruz FoundationLead sponsor
- Instituto Nacional de Infectologia, BrazilStudy director
- Conselho Nacional de Desenvolvimento Científico e TecnológicoCollaborator
- Rio de Janeiro State UniversityCollaborator
- Oswaldo Cruz FoundationReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.